🇺🇸 FDA
Patent

US 9845357

Integrin αvβ8 neutralizing antibody

granted A61KA61K2039/505A61P

Quick answer

US patent 9845357 (Integrin αvβ8 neutralizing antibody) held by The Regents of the University of California expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61P, A61P1/16, A61P11/00